Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Emulex Says Fred Cox Not To Seek Re-Election To Board - Quick Facts

RELATED NEWS
Trade ELX now with 
6/15/2012 8:36 AM ET

Emulex Corp. (ELX: Quote) said that Fred Cox, Emulex co-founder and current Chairman Emeritus, will not seek re-election to the Board at this year's Annual General Meeting of Shareholders.

Fred Cox served as CEO of Emulex for more than 12 years, from the company's inception until he retired from active management in October 1990. Cox then served as Emulex's non-executive chairman for an additional eight years. His planned retirement from the Board in November will mark 34 years of continuous service to the company.

Click here to receive FREE breaking news email alerts for Emulex Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After showing a lack of direction throughout much of the session, stocks ended Monday's trading modestly lower. The slightly lower close on the day partly offset the strength that was seen in the markets last week. The major averages ended the day below the unchanged line but off their lows for the session. President Barack Obama reportedly plans to deliver a much-anticipated speech on Thursday outlining his administration's evolving counterterrorism policies. Multiple news sources cited a White House official as saying that Obama will address the use of drones and plans to close the detention facility at Guantanamo Bay in a speech at the National Defense University. A second union representing immigration enforcement officers has expressed opposition to the Senate version of comprehensive immigration reform legislation, arguing that the bill fails to address the "insurmountable bureaucracy" at the agency that oversees lawful immigration to the U.S.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.